MesotheliomaDR logo

24/7 Patient Assistance: 760-405-8205

David Reese, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

Amgen

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

  • Education & Training

    dept_icon

    University of Cincinnati College of Medicine

    Medical School

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Amgen

    Languages: English/Spanish

    (805) 447-1000

    1 Amgen Center Dr

    Thousand Oaks, California 91320

    Read More
  • Publications & Memberships

    Dr. David Reese has contributed to 3 publications.

    Phase Ib study of recombinant human (rh)Apo2L/TRAIL in combination with paclitaxel, carboplatin, and bevacizumab (PCB) in patients (pts) with advanced non-small cell l...

    Soria J, Smit EF, Khayat D, Besse B, Burton J, Yang X, Hsu M, Braun A, Reese D, Blackhall F; J. Clin. Oncol.. 2008-05-20.

    See more >>

    Phase II study of docetaxel (D) plus bevacizumab (B) in Her/2 negative metastatic breast carcinoma (MBC).

    Chan D, Allen H, Hu E, Reese D, Patel G, Gottlieb C, Wax A, Sosa J, Slamon D, Kabbinavar F; J. Clin. Oncol.. 2006-06-20.

    See more >>

    HER2-positive breast cancer: update on Breast Cancer International Research Group trials.

    Nabholtz, J., Reese, D.M., Lindsay, M., Riva, A.; Clin Breast Cancer. 2002 Oct.

    See more >>